MyAverix Finance
NS · Healthcare
Infinium Pharmachem Ltd (INFINIUM)
Pharmaceuticals & Biotechnology
Infinium Pharmachem Ltd (INFINIUM) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $3.35B, P/E ratio is 30.75, net margin is 7.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INFINIUM
Infinium Pharmachem Ltd (INFINIUM) — FAQ
What is Infinium Pharmachem Ltd's market cap?
Infinium Pharmachem Ltd (INFINIUM) has a reported market cap of $3.35B (data as of 2026-07-10).
What is INFINIUM's P/E ratio?
The price-to-earnings (P/E) ratio for Infinium Pharmachem Ltd (INFINIUM) is 30.75 (data as of 2026-07-10).
Does Infinium Pharmachem Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Infinium Pharmachem Ltd (INFINIUM). Check the MyAverix Finance app for the latest dividend data.
What sector is Infinium Pharmachem Ltd in?
Infinium Pharmachem Ltd (INFINIUM) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is INFINIUM listed on?
INFINIUM is listed on NS.
What is Infinium Pharmachem Ltd's net margin?
Infinium Pharmachem Ltd (INFINIUM) reports a net margin of 7.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.